FADS3 Inhibitors

Epigallocatechin gallate (EGCG) is a catechin found in green tea that can inhibit the activity of fatty acid desaturases by competing with natural substrates. As FADS3 is a fatty acid desaturase involved in the desaturation of fatty acids, EGCG can lead to the functional inhibition of FADS3 by hindering its enzymatic activity.

PD98059 is a MEK inhibitor that interferes with the MAPK/ERK pathway. Since FADS3 activity can be regulated by phosphorylation events downstream of MEK, the use of PD98059 can indirectly inhibit FADS3 function by preventing its phosphorylation and subsequent activation.

LY294002 is a PI3K inhibitor that disrupts phosphoinositide signaling. Because PI3K can modulate lipid metabolism and the activity of enzymes like FADS3, LY294002 can indirectly inhibit FADS3 by altering lipid signaling pathways, potentially reducing substrate availability.

Manumycin A selectively inhibits farnesyltransferase, an enzyme involved in the post-translational modification of proteins. By inhibiting farnesylation, Manumycin A may affect the membrane association of proteins involved in lipid metabolism, indirectly reducing FADS3 functionality due to altered cellular localization.

Simvastatin is an HMG-CoA reductase inhibitor that lowers cholesterol biosynthesis. By reducing the synthesis of cholesterol, simvastatin may reduce the lipid substrate pool necessary for FADS3 function, thereby indirectly inhibiting its activity.

GW6471 is a peroxisome proliferator-activated receptor alpha (PPARα) antagonist. Since PPARα regulates fatty acid metabolism and may influence FADS3 expression, GW6471 can indirectly inhibit FADS3 by downregulating its expression through PPARα inhibition.

Triacsin C is an inhibitor of long-chain acyl-CoA synthetase, which activates fatty acids. By inhibiting this activation, Triacsin C decreases the availability of fatty acid substrates for FADS3, indirectly inhibiting its function.

Tunicamycin blocks N-linked glycosylation of proteins. If FADS3 undergoes glycosylation, tunicamycin could affect its stability or localization, indirectly inhibiting its function.

Cerulenin inhibits fatty acid synthase, thereby reducing fatty acid biosynthesis. With fewer fatty acids available, FADS3s activity can be indirectly inhibited due to the lack of substrates for desaturation.

C75 is a synthetic inhibitor of fatty acid synthase and carnitine palmitoyltransferase 1. By limiting fatty acid synthesis and transport, C75 can decrease the substrate pool for FADS3, leading to its functional inhibition.